FIELD: medicine.
SUBSTANCE: invention relates to the use of hydrochloride of 2,8-dimethyl-5-(2-phenylethyl)-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole (hereinafter – A·HCl), having noradrenergic and specifically serotonergic activity, or a pharmaceutical composition based on it for the treatment of people with generalized anxiety disorder (hereinafter – GAD). The invention also relates to a pharmaceutical composition based on the compound (A·HCl) and a method for the treatment of people with generalized anxiety disorder (GAD).
EFFECT: reduction in undesired side effects in the treatment of generalized anxiety disorder GAD.
10 cl, 9 dwg, 14 tbl, 12 ex
| Title | Year | Author | Number |
|---|---|---|---|
| LIGANDS OF ALPHA-ADRENOCEPTORS, DOPAMINE, HISTAMINE, IMIDAZOLINE AND SEROTONIN RECEPTORS AND USE THEREOF | 2008 |
|
RU2407744C2 |
| SUBSTITUTED 2,3,4,5-TETRAHYDRO-1H-PYRIDO[4,3-b]INDOLES, METHOD OF PRODUCTION AND APPLICATION THEREOF | 2007 |
|
RU2334747C1 |
| TETRAHYDRO-PYRAZOLO[1,5-a]PYRIDO-PYRIMIDINES - SEROTONIN 5-HT RECEPTOR ANTAGONISTS, METHODS OF PRODUCING AND USING SAID COMPOUNDS | 2008 |
|
RU2391343C1 |
| SUBSTITUTED 2-AMINO-3-SULFONYL-TETRAHYDRO-PYRAZOLO[1,5-a]PYRIDO-PYRIMIDINES-ANTAGONISTS OF SEROTONIN 5-HT RECEPTORS, METHODS OF PRODUCING AND USING SAID COMPOUNDS | 2008 |
|
RU2384581C2 |
| COCRYSTALLINE FORM OF 2,8-DIMETHYL-5-PHENETHYL-2,3,4,5-TETRAHYDRO-1H-PYRIDO[4,3-b]INDOLE | 2022 |
|
RU2806046C1 |
| SUBSTITUTED HYDRATED TIENO-PYRROLO [3,2-c] PYRIDINES, LIGANDS, PHARMACEUTICAL COMPOSITION AND ITS APPLICATION METHOD | 2010 |
|
RU2451686C1 |
| HISTAMINE RECEPTOR BLOCKERS FOR PHARMACEUTICAL COMPOSITIONS OF ANTIALLERGIC AND AUTOIMMUNE EFFECT | 2007 |
|
RU2339637C1 |
| SUBSTITUTED 2,3,4,5-TETRAHYDRO-1N-PYRIDO[4,3-b]INDOLES, METHOD OF OBTAINING THEM AND USE | 2007 |
|
RU2338745C1 |
| (3-ARYLSULPHONYL QUINOLIN-8-YL-DIALKYL-AMINES - SELECTIVE SEROTONIN 5-HT RECEPTOR ANTAGONISTS, METHODS FOR PRODUCTION AND USE THEREOF | 2012 |
|
RU2500672C1 |
| DERIVATIVES OF 1-(3-AMINOPHENYL)-6,8-DIMETHYL-5-(4-IODO-2-FLUORO-PHENYLAMINO)-3-CYCLOPROPYL-1H,6H-PYRIDO[4,3-d]PYRIMIDINE-2,4,7-TRIONE AS MEK1/2 INHIBITORS | 2015 |
|
RU2605400C1 |
